|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|5518504||1401070||2017||3 صفحه PDF||ندارد||دانلود کنید|
Fibroblast growth factor-21 (FGF21) levels are elevated in patients with primary mitochondrial disorders but have not been studied in patients with inborn errors of metabolism (IEM) known to have secondary mitochondrial dysfunction. We measured plasma FGF21 by ELISA in patients with and without IEM. FGF21 levels were higher in patients with IEM compared to without IEM (370Â pg/dL vs. 0â65Â pg/dL). Further study of FGF21 as a biomarker in IEM is warranted.
Journal: Molecular Genetics and Metabolism Reports - Volume 13, December 2017, Pages 52-54open access